ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,633,000 | +90.0% | 100,000 | 0.0% | 0.54% | +87.7% |
Q1 2019 | $2,438,000 | +71.1% | 100,000 | 0.0% | 0.28% | +53.2% |
Q4 2018 | $1,425,000 | -6.2% | 100,000 | 0.0% | 0.19% | +9.4% |
Q3 2018 | $1,520,000 | -9.4% | 100,000 | 0.0% | 0.17% | -12.8% |
Q2 2018 | $1,678,000 | +46.9% | 100,000 | +42.9% | 0.20% | +43.4% |
Q1 2018 | $1,142,000 | +41.7% | 70,000 | +11.1% | 0.14% | +38.8% |
Q4 2017 | $806,000 | +31.1% | 63,000 | +26.0% | 0.10% | +25.6% |
Q3 2017 | $615,000 | +47.1% | 50,000 | 0.0% | 0.08% | +39.3% |
Q2 2017 | $418,000 | -6.5% | 50,000 | 0.0% | 0.06% | -9.7% |
Q1 2017 | $447,000 | +408.0% | 50,000 | +400.0% | 0.06% | +376.9% |
Q4 2016 | $88,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |